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IN NEARLY all patients, Crohn's disease runs a chronic course, usually extending
over many years. The thirty-fourth President of the United States, Dwight D.
Eisenhower, had the disease for 46 years (Heaton et al, 1964). Without definitive
treatment, there is no real evidence that the inflammatory process will ever cease
spontaneously and the patient become permanently symptom-free. Progression of
Crohn's disease of the colon can often be seen in serial barium enema examina-
tions. It is much more difficult to obtain strictly comparable films of small intestinal
changes but progression probably does occur in some untreated patients (Marshak
and Linder, 1970). Often, however, it appears that the disease remains active in a
short length of lower ileum for years without spreading proximally. Recurrences
after inadequate surgical treatment are well known. The very chronic nature of
Crohn's disease is a major factor in planning the treatment of any patient in whom
the diagnosis has been made.
DIAGNOSIS
The diagnosis of Crohn's disease rests on four main pillars: (i) clinical history
and findings; (ii) radiological investigations; (iii) macroscopic appearances, and
(iv) histological findings. At least two out of the four must be presented to support
the diagnosis. The appearances on X-ray may not always correspond with the
clinical state of the patient. When multiple sections are cut, the classical epithelioid
cell granulomas and the giant cells will be seen on histological examination in two-
thirds of resected or biopsy specimens; their absence does not rule out Crohn's
disease. Today more emphasis is placed on the transmural extent of the inflamma-
tion and to fissure formation and rather less on Hadfield's (1939) classical criteria.
While the diagnosis is usually straightforward, in a quarter of all patients it may
only be possible to make the correct diagnosis after observing the behaviour of the
disease for several months or even years. On the periphery of any series of patients
with Crohn's disease there are always a few cases labelled "Unproven"; prolonged
follow-up may elucidate the nature of their illness.
NON-OPERATIVE TREATMENT
The decade of life in which Crohn's disease of the small intestine most often starts
is that between 20 and 30 years. This is the time when young men should be
earning their living and young women rearing their families - if Crohn's disease
has not rendered them infertile. With the cause and cure of the disease still
unknown, the doctor must carefully consider what line of treatment will enable
each patient to lead as normal and active a life as possible.
Medical therapy is usually tried first. Until recently the results were poor. In
Aberdeen, between 1955 and 1968, there were 145 patients with Crohn's disease,
59
Based on a lecture given to the Ulster Medical Society, 30 October 1969.including 30 patients where the colon was the site predominantly affected. Of the
145 patients, 83 had a trial of medical therapy lasting more than one month; only
16 (19 per cent) remain well, most of the others eventually requiring operation.
In extenuation, it must be admitted that in some of the failed cases treatment had
consisted solely of alleviating symptoms and had not included any concerted
attempt to combat infection and inflammation. Crohn's disease of the colon has
only been widely recognised for 10 years (Lockhart-Mummery and Morson, 1960),
so that long follow-up results are not available, but it seems that the condition may
be more responsive to medical therapy than is ileal Crohn's disease. Changes in
the colon can solmetimes regress very rapily when intensive medical treatment is
given.
General Measures
Adequate rest is obviously necessary in a chronic, debilitating illness. Sound
sleep at night should be ensured, but during the day the patient is better leading
as normal a life as his physical state permits. It is only when a patient sees that
hbe is falling behind his contemporaries that psychological problems arise.
Nutrition
With increased catabolism within the inflamed bowel wall, protein loss from
its ulcerated mucosa, and malabsorption from the lumen, the patient's weight falls
rapidly. Many females weigh between 35 and 45 kg. (5.5-7 stones) before treatment.
An element of subacute obstruction may make eating difficult. An enthusiastic
dietician and close co-operation from the nursing staff are essential if an intake of
2,500-3,500 calories per day is to be ensured (Clark and Lawder, 1969). Most of
the intake should consist of carbohydrate and protein. Green vegetables, peas,
beans and fruit that leave a considerable residue are better avoided. Mechanical
obstruction may have to be corrected before weight gain can be achieved.
Correction of Deficiencies
Resection of excessive lengths of intestine is likely to cause more severe deficiency
states than untreated Crohn's disease. A moderate degree of iron-deficiency
anaemia is common and usually responds to oral ferrous sulphate. Megaloblastic
anaemia is rare, but in 9 out of 10 untreated patients in Aberdeen the serum folate
level was subnormal. Folic acid in a dosage of 5-10 mg./day may be prescribed
for these patients. Although the lower ileum is the principal site of absorption of
vitamin B12, its uptake and serum level are usually normal unless more than
80 cm. of small intestine have been removed (Schofield, 1965); patients who have
had extensive resections may require monthly injections. Other patients unable
to eat fruit and vegetables should be given ascorbic acid, 0.5-1 gm./day, and a few
require vitamin B complex. When steatorrhoea is marked it is advisable to give
supplementary calcium. Magnesium deficiency has been noted in 10-15 per cent
of cases; it responds to magnesium hydroxide suspension, 20 ml. daily.
Anti-diarrhoeal agents
One of the most effective agents in reducing the frequency of bowel action is
Lomotil (Searle), 5 mg. given several times per day. Codeine phosphate is a useful
alternative. In the author's experience cholestyramine, which lessens colonic
irritation by unabsorbed bile salts, and lignin have been less consistently effective.
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Salazopyrin (Pharmacia) is the only anti-bacterial drug that has been used in
long-term treatment. There have been no controlled clinical trials of its efficacy
in Crohn's disease, although one is planned. fn addition the mode of action of
the drug is not known and even in untreated Crohn's disease remissions and
relapses are less clear-cut than in ulcerative colitis. Nevertheless, in a dosage of
1 gm. three or four times per day, sulphasalazine does seem to be beneficial in
the more florid stages of the disease.
Steroids
Oral prednisone and corticotrophin by injection have an anti-inflammatory
effect, but do not cure Crohn's disease. Given in high dosage, e.g. 30-40 mg. pre-
dnisone daily for several weeks, these drugs will diminish diarrhoea and lower the
E.S.R. They are more effective in younger patients with short histories, but they
do not prevent relapses or recurrences. Short courses may be used with advantage
to reduce the toxic manifestations of Crohn's disease before elective resection.
Nightly retention prednisone enemata are beneficial when the colon is involved.
Prior et al (1970) believe that steroid therapy may contribute to the increased
mortality in patients with Crohn's disease.
Immunosuppressive Drugs
Azathioprine is the latest drug used in treating Crohn's disease. It works in many
but not all cases (Brooke, Hoffman and Swarbrick, 1969). In Aberdeen, eight
patients with disease too extensive for resection, or with multiple external fistulae,
have been treated to date. Six have responded rapidly. One elderly lady with
several associated diseases has not responded at all; in another patient with multiple
fistulae arising from partial breakdown of an anastomosis, not unexpectedly the
fistulae have remained unhealed. In mid-1970 the optimum dosage and length of
treatment with azathioprine are not known. Small doses of 2 mg./kg. per day
have been given continuously or 5 mg./kg. daily for 5 days followed by two days'
treatment with steroids. While the ill-effects of immunosuppressive drugs were
probably over-publicised at the time of the cardiac transplantation failures,
undoubtedly they are potent weapons and should only be used when regular
supervision is possible.
SURGICAL TREATMENT
The need for regular supervision is one of the great disadvantages of conservative
management. Very few young people would accept a line of treatment if they
realised that it entailed regular attendance at hospital for the next 40 or 50 years.
Few people want to be permanent pill-swallowers. The alternative to this type of
medicated survival is surgery.
Indications for Operation
The most suitable type of case to operate on is one where there is localised
disease which has become quiescent spontaneously or after intensive medical
treatment. Inability to enjoy life and the failure of children to thrive are other
important considerations. Until the advent of azathioprine, external fistulae would
not heal until the underlying disease had been extirpated. Remote toxic manifesta-
tions in joints, eyes and skin usually will not subside without intestinal resection.
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However, if acute intestinal obstruction supervenes emergency operation is better
avoided if at all possible - conservative measures should be tried to relieve
temporarily the obstruction. The rare complications of free perforation and massive
haemorrhage demand urgent surgical intervention.
Operation is not advised when there is very extensive disease, multiple skip
areas or rapid progression of the inflammatory process. Further surgery is contra-
indicated in those unfortunate patients who develop a recurrence after earlier
resection; they should be treated by intensive medical therapy.
Type of Operation
Resection is the treatment of choice. Eighty per cent of patients have ileal
involvement. As well as the thickened ileum, the caecum and about 20 cm. of
ileum proximal to the upper macroscopic limit of the disease are excised and
the ileum anastomosed to the ascending colon. One short skip area can be ignored.
Multiple resections are to be avoided. At the proximal line of section the ends
should be opened to make sure no luminal ulcers are present (Atwell, Duthie and
Goligher, 1968). Gross rectal and perianal disease may necessitate abdomino-
perineal resection. Terminal ileostomy works well after colectomy, but there seems
little place for double-barrelled ileostomies and attempts to re-use grossly diseased
bowel.
When there is a large inflammatory mass in the right iliac fossa, with dense
adhesions to iliac vessels and ureter, short-circuit with exclusion is undoubtedly
the safer if less dramatic procedure. This operation will give long-lasting relief
of symptoms in almost 50 per cent of cases. Earlier fears about the development
of blind-loop syndromes and blown ileal stumps have proved largely unfounded.
PROGNOSIS
Crohn's disease has a high morbidity but a low initial mortality rate. Nevertheless
in a series of 300 patients followed for up to 30 years, Prior et al (1970) found
that the mortality among patients was about double that in an age and sex-matched
sample from the general population. Half the deaths were directly attributable to
Crohn's disease. The Aberdeen experience is almost identical.
The disappointing results of earlier medical regimes, and a possible explanation
for their failure, have already been referrred to. The long-term results of azathio-
prine are awaited with great interest. It is by no means certain that even a long
course of the drug will permanently cure a patient of the tendency to react against
his own intestines - if Crohn's disease is caused by some auto-immunological
process. It would be even more naive to assume that the surgeon's scalpel could
eradicate such a self-destructive propensity. Nevertheless resection offers the patient
the best prospect of long periods of normal health.
Bcause the ileum is the site most often affected, the results of ileal resection
are of particular interest. In Aberdeen, 61 patients had primary resections for ileal
disease in the years up to 1966. One patient died following operation, an operative
mortality of under 2 per cent. The remainder were followed up for at least two
years. The chances of recurrence were then calculated according to the actuarial
method of Lennard-Jones and Stalder (1967), which is based on the number of
patients at risk at the start of each year. After two years the recurrence rate was
6213 per cent, rising to 18 per cent after five years. At ten years the symptomatic
recurrence rate was 33 per cent. In other words, when it is technically feasible for
ileal disease, resection offers two patients out of three some ten years of active, useful
life with freedom from the dangers and inconvenience that are inseparable from
prolonged drug therapy.
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